semaglutide arrhythmia Comparative Cardiovascular Pharmacovigilance of and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026) Impact of SGLT2 Inhibitors on

Diabetes 2013;62:e167

HOW IT WORKS Semaglutide is administered via a simple injection just under the skin (subcutaneously), typically in the abdomen

In the stomach, GLP-1 suppresses gastric acid secretion, slows digestion, and prolongs feelings of fullness

It is an unapproved investigational compound that did not complete clinical development, has not been authorized by Health Canada for any human or veterinary indication, and is not intended to diagnose, treat, cure, or prevent any disease

NHS access usually needs a BMI of 35 or above with a weight-related condition, through a specialist weight-management service, or the phased Mounjaro rollout for the highest-need group